Lilly Keeps Gaining Market Share On Novo Nordisk, Orforglipron Nears FDA Filing

 
• By Joseph Haas
  
Zepbound and Mounjaro helped Lilly continue taking US market share from rival Novo Nordisk (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business